These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 8813583)

  • 1. Antidepressant drugs given repeatedly change the binding of the dopamine D2 receptor agonist, [3H]N-0437, to dopamine D2 receptors in the rat brain.
    Maj J; Dziedzicka-Wasylewska M; Rogoz R; Rogóz Z; Skuza G
    Eur J Pharmacol; 1996 May; 304(1-3):49-54. PubMed ID: 8813583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of antidepressant drugs administered repeatedly on the dopamine D3 receptors in the rat brain.
    Maj J; Dziedzicka-Wasylewska M; Rogoz R; Rogóz Z
    Eur J Pharmacol; 1998 Jun; 351(1):31-7. PubMed ID: 9698202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of antidepressant drugs on the dopamine D2/D3 receptors in the rat brain differentiated by agonist and antagonist binding--an autoradiographic analysis.
    Rogoz R; Dziedzicka-Wasylewska M
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Mar; 359(3):178-86. PubMed ID: 10208304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeated administration of antidepressants enhances agonist affinity for mesolimbic D2-receptors.
    Klimek V; Maj J
    J Pharm Pharmacol; 1989 Aug; 41(8):555-8. PubMed ID: 2571700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of repeated treatment with tianeptine and fluoxetine on central dopamine D(2) /D(3) receptors.
    Dziedzicka-Wasylewska M; Rogoz Z; Skuza G; Dlaboga D; Maj J
    Behav Pharmacol; 2002 Mar; 13(2):127-38. PubMed ID: 11981225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressant drugs attenuate 7-OH-DPAT-induced hypoactivity in rats.
    Rogóz Z; Dziedzicka-Wasylewska M
    Pol J Pharmacol; 2000; 52(5):331-6. PubMed ID: 11334224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeated imipramine treatment enhances the 7-OH-DPAT-induced hyperactivity in rats: the role of dopamine D2 and D3 receptors.
    Rogóz Z; Skuza G
    Pol J Pharmacol; 2001; 53(6):571-6. PubMed ID: 11985330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of prolonged treatment with imipramine on the biosynthesis and functional characteristics of D2 dopamine receptors in the rat caudate putamen.
    Dziedzicka-Wasylewska M; Rogoz R
    Br J Pharmacol; 1998 Mar; 123(5):833-8. PubMed ID: 9535010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective increase of dopamine D3 receptor gene expression as a common effect of chronic antidepressant treatments.
    Lammers CH; Diaz J; Schwartz JC; Sokoloff P
    Mol Psychiatry; 2000 Jul; 5(4):378-88. PubMed ID: 10889548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of repeated treatment with milnacipran on the central dopaminergic system.
    Rogóz Z; Margas W; Dlaboga D; Góralska M; Dziedzicka-Wasylewska M; Maj J
    Pol J Pharmacol; 2000; 52(2):83-92. PubMed ID: 10949109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic treatment with antidepressants decreases the number of [3H]SCH 23390 binding sites in the rat striatum and limbic system.
    Klimek V; Nielsen M
    Eur J Pharmacol; 1987 Jul; 139(2):163-9. PubMed ID: 3308491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated administration of fluoxetine, desipramine and tranylcypromine increases dopamine D2-like but not D1-like receptor function in the rat.
    Ainsworth K; Smith SE; Sharp T
    J Psychopharmacol; 1998; 12(3):252-7. PubMed ID: 10958251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidepressant-like properties of the anti-Parkinson agent, piribedil, in rodents: mediation by dopamine D2 receptors.
    Brocco M; Dekeyne A; Papp M; Millan MJ
    Behav Pharmacol; 2006 Nov; 17(7):559-72. PubMed ID: 17021388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of dopamine D2 receptor in the behavioral effects of imipramine--study with the use of antisense oligonucleotides.
    Dziedzicka-Wasylewska M; Kolasiewicz W; Rogóz Z; Margas W; Maj J
    J Physiol Pharmacol; 2000 Sep; 51(3):401-9. PubMed ID: 11016860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parallel changes in dopamine D2 receptor binding in limbic forebrain associated with chronic mild stress-induced anhedonia and its reversal by imipramine.
    Papp M; Klimek V; Willner P
    Psychopharmacology (Berl); 1994 Aug; 115(4):441-6. PubMed ID: 7871087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of combined treatment with imipramine and amantadine on the central dopamine D2 and D3 receptors in rats.
    Rogóz Z; Dlaboga D; Dziedzicka-Wasylewska M
    J Physiol Pharmacol; 2003 Jun; 54(2):257-70. PubMed ID: 12832726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeated administration of a dopamine D1 receptor agonist reverses the increased proportions of striatal dopamine D1High and D2High receptors in methamphetamine-sensitized rats.
    Shuto T; Seeman P; Kuroiwa M; Nishi A
    Eur J Neurosci; 2008 May; 27(10):2551-7. PubMed ID: 18489579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of (+)-7-hydroxy-N,N-di-n-[3H]propyl-2-aminotetralin binding following intracerebroventricular administration of a nitric oxide generator.
    Wallace DR; Booze RM
    Neurochem Res; 1997 Feb; 22(2):163-70. PubMed ID: 9016841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Some behavioural effects of antidepressant drugs are time-dependent.
    Dziedzicka-Wasylewska M; Rogóz Z; Margas W; Dlaboga D; Góralska M
    Prog Neuropsychopharmacol Biol Psychiatry; 2001 Feb; 25(2):373-93. PubMed ID: 11294483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: I. Interaction with cloned human (h)5-HT1A, dopamine hD2/hD3 and h alpha2A-adrenergic receptors in relation to modulation of cortical monoamine release and activity in models of potential antidepressant activity.
    Millan MJ; Newman-Tancredi A; Rivet JM; Brocco M; Lacroix P; Audinot V; Cistarelli L; Gobert A
    J Pharmacol Exp Ther; 1997 Jul; 282(1):132-47. PubMed ID: 9223549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.